latest news
AstraZeneca selects new £330 million global R&D center and corporate headquarters in Cambridge (UK)
AstraZeneca today announced that its new UK-based global research and development center and corporate headquarters will be located at the Cambridge Biomedical Campus on the southern outskirts of the city. By 2016, the new site will house a highly-skilled workforce of approximately 2,000.
As announced on March 18, 2013, the investment in a £330 million (approx. €386 million) facility in Cambridge is part of the company’s move to create strategic global R&D centers in the UK, US and Sweden to improve pipeline productivity and to establish AstraZeneca as a global leader in biopharmaceutical innovation.
pbb and Helaba provide € 163 million credit facility to finance the acquisition of the Pacific Tower in La Defense (FR)
pbb Deutsche Pfandbriefbank and Helaba have jointly provided a € 163 million senior loan to Tishman Speyer. The…
AXA announces €10 billion infrastructure debt commitment
AXA announced today that it has increased its exposure to the infrastructure debt market with a commitment to…
SEGRO to acquire prime warehouse in The Midlands for £18.1 million (UK)
SEGRO is pleased to announce that it has exchanged contracts to acquire a modern distribution warehouse in Burton-Upon-Trent…
Auchan hypermarket to open in Prospect, Kiev’s new shopping and entertainment center (UA)
A partnership agreement has recently been signed between Comfort Market Luks – the investor of the project –…
features
Thought Leaders
Retail Minds
Who's Who
Industry Trends
PROMINENT PROJECTS
Cities
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |


